Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma
| dc.contributor.author | Walsh, Garry Michael | |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2013-03-15T10:29:01Z | |
| dc.date.available | 2013-03-15T10:29:01Z | |
| dc.date.issued | 2013-01-09 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 5 | |
| dc.format.extent | 146590 | |
| dc.identifier | 20890796 | |
| dc.identifier | 12123d6c-27d1-46f5-b329-ae02a2066ff2 | |
| dc.identifier.citation | Walsh, G M 2013, 'Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma', Biologics: Targets & Therapy, vol. 7, pp. 7-11. https://doi.org/10.2147/BTT.S30133 | en |
| dc.identifier.doi | 10.2147/BTT.S30133 | |
| dc.identifier.issn | 1177-5475 | |
| dc.identifier.uri | http://hdl.handle.net/2164/2709 | |
| dc.identifier.vol | 7 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Biologics: Targets & Therapy | en |
| dc.subject | IL-5 | en |
| dc.subject | asthma | en |
| dc.subject | eosinophil | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma | en |
| dc.type | Journal article | en |